First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
about
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
First-line axitinib versus sor ...... oup analyses of Phase III data
@en
type
label
First-line axitinib versus sor ...... oup analyses of Phase III data
@en
prefLabel
First-line axitinib versus sor ...... oup analyses of Phase III data
@en
P2093
P356
P1433
P1476
First-line axitinib versus sor ...... oup analyses of Phase III data
@en
P2093
Brad Rosbrook
Jinwan Wang
Ming Jiang
Xiubao Ren
Ying Cheng
P356
10.2217/FON-2018-0442
P50
P577
2018-07-30T00:00:00Z